ASX - By Stock
|
AN1 |
Re:
Publication: Biomarkers Have Higher Diagnostic and Prognostic Potential Than Other Tools
|
|
let.it.ride
|
38 |
11K |
4 |
13/09/17 |
13/09/17 |
ASX - By Stock
|
38
|
11K
|
4
|
|
ASX - By Stock
|
AN1 |
Re:
David king
|
|
let.it.ride
|
14 |
7.2K |
4 |
12/09/17 |
12/09/17 |
ASX - By Stock
|
14
|
7.2K
|
4
|
|
ASX - By Stock
|
AN1 |
Re:
evolisus.com
|
|
let.it.ride
|
54 |
15K |
1 |
11/09/17 |
11/09/17 |
ASX - By Stock
|
54
|
15K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Nature Paper MK in Melanoma
|
|
let.it.ride
|
53 |
20K |
4 |
11/09/17 |
11/09/17 |
ASX - By Stock
|
53
|
20K
|
4
|
|
ASX - By Stock
|
AN1 |
investing mega trends: biotechs
|
|
let.it.ride
|
0 |
416 |
0 |
07/09/17 |
07/09/17 |
ASX - By Stock
|
0
|
416
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Neiman Marcus
|
|
let.it.ride
|
150 |
57K |
2 |
07/09/17 |
07/09/17 |
ASX - By Stock
|
150
|
57K
|
2
|
|